Genome Medical Overview

  • Founded
  • 2016
Founded
  • Status
  • Private
  • Employees
  • 108
Employees
  • Latest Deal Type
  • 2ndary - Private
  • Investors
  • 19

Genome Medical General Information

Description

Operator of a cloud-based genomic care delivery platform intended to bridge the gap between advancing genome technology and current medical practice. The company's platform connects individuals and health care providers to genetic experts, providing a genetic assessment to individuals regarding the benefits of testing and thereafter creating a personalized clinical action plan to incorporate test results into actionable steps for precision health care, enabling patients to make informed treatment decisions at low costs and medical practitioners to accelerate disease diagnosis.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Clinics/Outpatient Services
Other Industries
Managed Care
Other Healthcare Technology Systems
Practice Management (Healthcare)
Primary Office
  • 701 Gateway Boulevard
  • Suite 380
  • San Francisco, CA 94080
  • United States
+1 (877) 000-0000

Genome Medical Timeline

2018201920202021
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Genome Medical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Secondary Transaction - Private 0000 Completed Generating Revenue
5. Early Stage VC (Series B) 23-Jul-2020 0000 0000 Completed Generating Revenue
4. Accelerator/Incubator 01-Oct-2018 0000 Completed Generating Revenue
3. Early Stage VC (Series A1) 22-Dec-2017 0000 0000 Completed Generating Revenue
2. Early Stage VC (Series A) 12-Apr-2017 $10M $12M Completed Generating Revenue
1. Seed Round 01-Nov-2016 $2M $2M Completed Startup
To view Genome Medical’s complete valuation and funding history, request access »

Genome Medical Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series A1 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series A 12,274,454 $0.000100 $0.05 $0.81 $0.81 1x $0.81 21.11%
Seed 4,251,063 $0.000100 $0.03 $0.53 $0.53 1x $0.53 7.31%
To view Genome Medical’s complete cap table history, request access »

Genome Medical Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Operator of a cloud-based genomic care delivery platform intended to bridge the gap between advancing genome technology
Clinics/Outpatient Services
San Francisco, CA
108 As of 2021
0000
000000 - 000 0000

00000000

re et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi u
00000 0000000000 00000000
Minneapolis, MN
00 As of 0000
000.00
0000000000 0 000.00

00000

velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, s
00000 0000000000 0000000000 0000000
Paris, France
00 As of 0000
000.00
0000 0000-00-00
00000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Genome Medical Competitors (8)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
GeneMatters Venture Capital-Backed Minneapolis, MN 00 000.00 0000000000 0 000.00
00000 Venture Capital-Backed Paris, France 00 000.00 00000000000 000.00
00000000000 Venture Capital-Backed Saint Petersburg, FL 000 000.00 0000000000 0 000.00
0000000 0000000000 Formerly PE-Backed Westwood, MA 0000 00000000
000000000 00000000 Formerly VC-backed Espoo, Finland 000 000.00 000000&0 000.00
You’re viewing 5 of 8 competitors. Get the full list »

Genome Medical Executive Team (15)

Name Title Board Seat Contact Info
Lisa Alderson Co-Founder & Chief Executive Officer
Brandon Poe Chief Financial Officer
Kristin Ashcraft Chief Operating Officer
Hunt Willard Ph.D Chief Scientific Officer & Senior Vice President of Medical Affairs
Marco Barcella Chief Product Officer
You’re viewing 5 of 15 executive team members. Get the full list »

Genome Medical Board Members (10)

Name Representing Role Since
Amy Belt Raimundo Kaiser Permanente Ventures Board Member 000 0000
Jessica Zeaske Ph.D Echo Health Ventures Board Member 000 0000
Keith Figlioli Self Board Observer 000 0000
Nicholas Naclerio Ph.D Illumina Ventures Board Member 000 0000
Randy Scott Ph.D Genome Medical Co-Founder & Chairman 000 0000
You’re viewing 5 of 10 board members. Get the full list »

Genome Medical Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Genome Medical Investors (19)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Alumni Ventures Group Venture Capital Minority 000 0000 000000 0
Avestria Ventures Venture Capital Minority 000 0000 000000 0
Casdin Capital Hedge Fund Minority 000 0000 000000 0
Dreamers VC Venture Capital Minority 000 0000 000000 0
Echo Health Ventures Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 19 investors. Get the full list »